We are live on ! Find out more
DSI

Daiwa SB Investments Portfolio holdings

AUM $506M
1-Year Est. Return 11%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+11%
3 Year Est. Return
+60.53%
5 Year Est. Return
+93.17%
10 Year Est. Return
AUM
$380M
AUM Growth
-$7.18M
Cap. Flow
-$21.7M
Cap. Flow %
-5.7%
Top 10 Hldgs %
32.3%
Holding
250
New
39
Increased
58
Reduced
116
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Consumer Discretionary 13.71%
3 Healthcare 11.35%
4 Financials 9.7%
5 Consumer Staples 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIL icon
101
Gildan
GIL
$10.6B
$573K 0.15%
22,580
-200
-0.9% -$5.33K
SHW icon
102
Sherwin-Williams
SHW
$88.1B
$556K 0.15%
6,210
-90
-1% -$7.95K
BXP icon
103
Boston Properties
BXP
$10.8B
$550K 0.14%
4,370
-120
-3% -$14.9K
MAS icon
104
Masco
MAS
$14.7B
$520K 0.14%
16,450
-1,980
-11% -$63.5K
ALL icon
105
Allstate
ALL
$68.2B
$493K 0.13%
6,650
+200
+3% +$14.1K
SPWR
106
DELISTED
SunPower Corporation Common Stock
SPWR
$471K 0.12%
108,875
AMGN icon
107
Amgen
AMGN
$226B
$458K 0.12%
3,130
+2,700
+628% +$406K
XL
108
DELISTED
XL Group Ltd.
XL
$442K 0.12%
11,870
-350
-3% -$12.6K
TMO icon
109
Thermo Fisher Scientific
TMO
$222B
$419K 0.11%
+2,970
New +$438K
ILMN icon
110
Illumina
ILMN
$29B
$384K 0.1%
3,084
WFC icon
111
Wells Fargo
WFC
$265B
$379K 0.1%
6,880
-106,490
-94% -$5.35M
FPRX
112
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$313K 0.08%
6,240
-1,260
-17% -$66.2K
JNJ icon
113
Johnson & Johnson
JNJ
$631B
$306K 0.08%
2,660
-50
-2% -$5.78K
ALNY icon
114
Alnylam Pharmaceuticals
ALNY
$29B
$304K 0.08%
8,111
+3,300
+69% +$138K
CTAS icon
115
Cintas
CTAS
$81.1B
$300K 0.08%
10,400
-10,800
-51% -$303K
BNS icon
116
Scotiabank
BNS
$108B
$269K 0.07%
+4,840
New +$264K
PFE icon
117
Pfizer
PFE
$154B
$264K 0.07%
8,569
+611
+8% +$18.7K
IBM icon
118
IBM
IBM
$223B
$257K 0.07%
1,621
+62
+4% +$9.44K
ALDR
119
DELISTED
Alder Biopharmaceuticals
ALDR
$250K 0.07%
12,040
-3,960
-25% -$103K
INTC icon
120
Intel
INTC
$492B
$246K 0.06%
6,790
-390
-5% -$14K
AGIO icon
121
Agios Pharmaceuticals
AGIO
$1.95B
$242K 0.06%
5,800
-2,428
-30% -$127K
GM icon
122
General Motors
GM
$77.2B
$211K 0.06%
6,070
-220
-3% -$7.39K
CMCSA icon
123
Comcast
CMCSA
$89.4B
$200K 0.05%
5,800
+200
+4% +$6.68K
WMT icon
124
Walmart Inc
WMT
$897B
$198K 0.05%
8,580
-240
-3% -$5.6K
LMT icon
125
Lockheed Martin
LMT
$139B
$197K 0.05%
790
+20
+3% +$5K

Similar funds

Daiwa SB Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Daiwa SB Investments held 250 positions worth $380M, down 1.9% from $387M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa SB Investments withdrew a net $21.7M in Q4 2016, closing 14 positions and reducing 116 holdings. Its most notable exit was Cardinal Health, an estimated $9.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Daiwa SB Investments opened a new position in PNC Financial Services worth $1.17M.

  • Daiwa SB Investments's largest Q4 2016 buy was PNC Financial Services: 9,960 shares worth $1.17M.
  • Daiwa SB Investments added most to J.M. Smucker in Q4 2016, an estimated $3.54M increase.
  • Daiwa SB Investments's biggest Q4 2016 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $6.38M.
  • Daiwa SB Investments fully exited Cardinal Health in Q4 2016, selling an estimated $9.43M.
  • Daiwa SB Investments's ten largest holdings make up 32% of its $380M portfolio in Q4 2016.
  • Daiwa SB Investments opened 39 new positions and closed 14 in Q4 2016.
  • Daiwa SB Investments's portfolio value fell 1.9% quarter-over-quarter to $380M.

Based on Daiwa SB Investments's 13F filing for Q4 2016, filed 11 Jan 2017.